Publications

COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review

Galgut O. et al, (2024), Vaccine: X, 20

Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection

Jindal J. et al, (2024), Metabolism, 156035 - 156035

Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.

Suwarti S. et al, (2024), BMC infectious diseases, 24

Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.

Duyvesteyn HME. et al, (2024), Structure (London, England : 1993)

Dysregulated immunologic landscape of early host response in melioidosis.

Rongkard P. et al, (2024), JCI insight

Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam.

Thanh TT. et al, (2024), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 147

Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.

Lim YJ. et al, (2024), British journal of haematology, 205, 440 - 451

Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening.

Clarke R. et al, (2024), NPJ vaccines, 9

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

Jackson S. et al, (2024), The Lancet Microbe, 5, 655 - 668

Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.

Peerawaranun P. et al, (2024), Diabetic medicine : a journal of the British Diabetic Association

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Goodyear CS. et al, (2024), The Lancet. Rheumatology, 6, e339 - e351

Implications of suboptimal measles immunity in UK health-care workers.

Ho A. et al, (2024), Lancet (London, England)

A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity

Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Schumacher AE. et al, (2024), The Lancet, 403, 1989 - 2056

Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery

Ali M. et al, (2024), Clinical and Experimental Immunology

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nature communications, 15

Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.

IHME Pathogen Core Group None., (2024), The Lancet. Infectious diseases

Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study

Browne AJ. et al, (2024), The Lancet Global Health, 12, e406 - e418

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.

Zhou D. et al, (2024), Nature communications, 15

Cookies on this website

Publications